drugset / Trial / NCT04752137

Intraoperative Tumor Margin Identification With ICG Dye Imaging

NCT04752137

Phase 2 Recruiting 100 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

In this research study we want to learn more about the use of indocyanine green (ICG) during bone or soft tissue mass resections. Indocyanine green (ICG) is a type of dye that is used in medical diagnostics. We want to determine if ICG-guided tumor resection is more effective in obtaining negative margins. Lastly, we want to assess traditional oncologic outcomes of local recurrence, time to metastatic disease, and overall and disease specific survival.

Timeline

Start
2022-05-25
Primary completion
2028-04-01
Completion
2030-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Intravenous

Indications